Substance P, insulinlike growth factor 1, and surface healing.
暂无分享,去创建一个
P. B. Taylor | C. Murphy | T. Reid | N. Barney | Catherine H. Lee | Amanda L Whiteman | C. Murphy | C. Murphy
[1] J. Baum,et al. Treatment of persistent corneal epithelial defect with extended wear of a fluid-ventilated gas-permeable scleral contact lens. , 2000, American journal of ophthalmology.
[2] T. Chikama,et al. Direct observation of corneal nerve fibres in neurotrophic keratopathy by confocal biomicroscopy , 1999, The Lancet.
[3] K. Fukuda,et al. Treatment of neurotrophic keratopathy with substance-P-derived peptide (FGLM) and insulin-like growth factor I , 1998, The Lancet.
[4] A. Lambiase,et al. Topical treatment with nerve growth factor for corneal neurotrophic ulcers. , 1998, The New England journal of medicine.
[5] C. Murphy,et al. Neurotrophic and anhidrotic keratopathy treated with substance P and insulinlike growth factor 1. , 1997, Archives of ophthalmology.
[6] S. Tseng,et al. Amniotic membrane transplantation for persistent epithelial defects with ulceration. , 1997, American journal of ophthalmology.
[7] C. Murphy,et al. Synergistic effects of substance P with insulin‐like growth factor‐1 on epithelial migration of the cornea , 1996, Journal of cellular physiology.
[8] K. Tsubota,et al. Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Stevens-Johnson syndrome. , 1996, American journal of ophthalmology.